BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25818264)

  • 21. Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.
    Fernández-Pascual E; González-García FJ; Angulo J; Cerezo E; Quintana LM; Turo J; Martínez-Ballesteros C; Carballido J; Martínez-Salamanca JI
    BJU Int; 2019 Dec; 124(6):1055-1062. PubMed ID: 31033130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease.
    Anaissie J; Powers MK; Hellstrom WJ; Yafi FA
    Drugs Today (Barc); 2015 Aug; 51(8):457-68. PubMed ID: 26380384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
    Jordan GH
    J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
    Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
    J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
    Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
    J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of Collagenase Clostridium histolyticum Injection Therapy for Peyronie Disease in Patients Continuing Antiplatelet or Anticoagulant Therapy.
    Amighi A; Regets KV; Nork JJ; Mendhiratta N; Mills JN; Eleswarapu SV
    J Sex Med; 2020 Feb; 17(2):353-356. PubMed ID: 31866126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
    Sukumar S; Pijush DB; Brandes S
    J Sex Med; 2020 Jan; 17(1):111-116. PubMed ID: 31759930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
    Natale C; McLellan DM; Yousif A; Hellstrom WJG
    Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
    El-Khatib FM; Towe M; Yafi FA
    World J Urol; 2020 Feb; 38(2):299-304. PubMed ID: 31093703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie's Disease with Calcified Plaques.
    Masterson TA; Atuluru P; Zucker I; Molina M; Ibrahim E; Nackeeran S; Kava B; Ramasamy R
    Eur Urol Focus; 2023 Jan; 9(1):55-59. PubMed ID: 36272924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms.
    Yang KK; Bennett N
    Urology; 2016 Aug; 94():143-7. PubMed ID: 27211926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
    Abdel Raheem A; Johnson M; Ralph D; Garaffa G
    Minerva Urol Nefrol; 2018 Aug; 70(4):380-385. PubMed ID: 29761688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
    Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
    J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie's disease: a review of the literature.
    Masterson TA; Rezk A; Ramasamy R
    World J Urol; 2020 Feb; 38(2):279-285. PubMed ID: 31250098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
    Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
    J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
    Alom M; Sharma KL; Toussi A; Kohler T; Trost L
    J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study.
    Cocci A; Russo GI; Briganti A; Salonia A; Cacciamani G; Capece M; Falcone M; Timpano M; Cito G; Verze P; Giammusso B; Morgia G; Mirone V; Minervini A; Gacci M; Cai T; Serni S; Carini M; Giubilei G; Mondaini N
    BJU Int; 2018 Oct; 122(4):680-687. PubMed ID: 29791971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
    Abdel Raheem A; Johnson M; Abdel-Raheem T; Capece M; Ralph D
    Sex Med Rev; 2017 Oct; 5(4):529-535. PubMed ID: 28874327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of collagenase Clostridium histolyticum in men with ventral curvatures: an updated series.
    Larson H; Savage J; Brearton K; Warner R; Ziegelmann M; Kohler T; Trost L
    J Sex Med; 2024 Jan; 21(2):169-174. PubMed ID: 38141054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
    Bajic P; Wiggins AB; Ziegelmann MJ; Levine LA
    J Sex Med; 2020 May; 17(5):1005-1011. PubMed ID: 32127330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.